InstalabCMV Antibody Panel
Should you take a CMV Antibody Panel test?
This test is most useful if any of these apply to you.
2 biomarkers included
- CMV IgGThe long-lived memory antibody that records whether you have ever been infected with cytomegalovirus. A positive result means the virus lives dormantly in you; a negative result means you are still susceptible to a first infection.Why it mattersA negative IgG flags susceptibility to a first infection, which carries the highest risk of harm to a pregnancy or a virus-negative transplant recipient.
- CMV IgMThe early-response antibody that rises during recent or active infection. Its presence flags the possibility of a new or reactivated infection and prompts confirmatory testing rather than serving as a diagnosis.Why it mattersA positive IgM signals possible recent infection but needs avidity or DNA-based confirmation, since it is frequently falsely positive or long-persisting.
About CMV Antibody Panel
Most adults carry cytomegalovirus (a common herpes-family virus, called CMV) without ever knowing it. It usually causes no symptoms, then settles in for life, staying quietly in the body. For a healthy person this rarely matters.
In two situations it matters a great deal: pregnancy and a weakened immune system. This panel reads two antibodies to answer a question with real stakes, namely whether you have been infected and whether that infection could be recent.
What This Panel Reveals
The panel covers two questions that one antibody cannot answer alone. The first antibody, a long-lived memory antibody (IgG), records whether your immune system has ever met the virus. Once it appears, it usually stays for life, so a positive IgG means you carry the virus in a dormant form and a negative IgG means you have never been infected.
The second antibody, the one your body makes first during a new infection (IgM), points to a recent or active immune response. On its own, IgM is a noisy signal. It can linger for months, reappear when a dormant infection flares, or turn positive by mistake when another virus such as Epstein-Barr is present. Read together, the two antibodies sort you into a clearer picture than either gives alone.
How to Read Your Results Together
The value of this panel is in the combination. IgG sets your baseline status, and IgM flags whether something recent may be happening on top of it.
| Pattern | What It Suggests | What It Means For You |
|---|---|---|
| IgG negative, IgM negative | No evidence of past infection | You are still susceptible. In pregnancy, prevention habits matter most here. |
| IgG positive, IgM negative | Past infection, now dormant | The most common result in adults. Usually no action needed. |
| IgG positive, IgM positive | Possible recent or reactivated infection | Not a diagnosis on its own. Confirm with an IgG avidity test or a DNA-based test. |
| IgG negative, IgM positive | Very early infection or a false positive | Repeat or confirmatory testing is usually needed. |
The stakes behind these patterns are clearest in pregnancy. A first-time (primary) infection during pregnancy passes to the baby in roughly 30% to 40% of cases, and about 36.8% when it happens in the first trimester. Timing drives the harm: among babies infected after a first-trimester primary infection, pooled data report sensorineural (nerve-related) hearing loss in 22.8%, while infections later in pregnancy rarely cause lasting problems.
What to Do with Your Results
A positive IgM is a prompt, not a verdict. Because IgM alone confirms a recent primary infection in only a minority of cases (one cohort confirmed it in 16.4% of IgM-positive pregnant women using follow-up testing), the next step is an IgG avidity test. Low avidity points to an infection within the last 3 to 4 months, while high avidity means the infection happened well before that.
If you are pregnant and results suggest a recent infection, a maternal-fetal medicine specialist can arrange a DNA-based test (PCR) of amniotic fluid, which detects fetal infection far more reliably than antibodies. If you are preparing for a transplant, your IgG status is used to match donor and recipient, since a virus-negative recipient receiving an organ from a virus-positive donor carries the highest risk of CMV disease.
Serial testing is meaningful when you start out negative. A virus-negative person who becomes pregnant benefits from repeat testing during pregnancy, and updated guidance in some countries recommends first-trimester screening with monthly retesting through 24 weeks in those who remain negative.
When Results Can Be Misleading
Several factors distort both antibodies at once. IgM can cross-react with Epstein-Barr virus (EBV) and can turn positive during other inflammatory illnesses, and it can persist for months to over a year after an infection has resolved. Different labs also report antibody levels differently, so serial results are best compared within one lab.
If your immune system is suppressed, by transplant medications or chemotherapy, antibody results become unreliable, and a recent transfusion or immunoglobulin infusion can produce false readings. In these settings, a DNA-based viral load test (PCR), not antibody serology, is the tool used to detect and track active infection.